Activation of α7nACh receptor protects against acute pancreatitis through enhancing TFEB-regulated autophagy

Biochim Biophys Acta Mol Basis Dis. 2020 Dec 1;1866(12):165971. doi: 10.1016/j.bbadis.2020.165971. Epub 2020 Sep 18.

Abstract

Acute pancreatitis (AP) is associated with impaired acinar cell autophagic flux, intracellular zymogen activation, cell necrosis and inflammation. Activation of the cholinergic system of vagus nerve has been shown to attenuate AP, but the effect of organ-intrinsic cholinergic system on pancreatitis remains unknown. In this study, we aim to examine the effect of α7 nicotinic acetylcholine receptor (α7nAChR) stimulation within the pancreas during AP. In vivo, AP was induced by caerulein plus LPS or ethanol plus palmitoleic acid in mice. In vitro, pancreatic acini were isolated and subjected to cholecystokinin (CCK) stimulation. Mice or acini were pre-treated with PNU-282987 (selective α7nAChR agonist) or methyllycaconitine citrate salt (selective α7nAChR antagonist). Pancreatitis severity, acinar cell injury, autophagic flux, and transcription factor EB (TFEB) pathway were analyzed. Both caerulein plus LPS in vivo and CCK in vitro led to an up-regulation of α7nAChR, indicating activation of pancreas-intrinsic α7nAChR signaling during AP. PNU-282987 decreased acinar cell injury, trypsinogen activation and pancreatitis severity. Conversely, methyllycaconitine citrate salt increased acinar cell injury and aggravated AP. Moreover, activation of α7nAChR by PNU-282987 promoted autophagic flux as indicated by reduced p62, increased LysoTracker staining and decreased number of autolysosomes with undegraded contents. Furthermore, PNU-282987 treatment significantly increased TFEB activity in pancreatic acinar cells. α7nAChR activation also attenuated pancreatic inflammation and NF-κB activation. Our results showed that activation of α7nAChR protected against experimental pancreatitis through enhancing TFEB-mediated acinar cell autophagy, suggesting that activation of pancreas-intrinsic α7nAChR may serve as an endogenous protective mechanism during AP.

Keywords: Acute pancreatitis; Autophagic flux; Lysosomal degradation; TFEB; α7nAChR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aconitine / administration & dosage
  • Aconitine / analogs & derivatives
  • Aconitine / pharmacology
  • Animals
  • Autophagy* / drug effects
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / metabolism*
  • Benzamides / administration & dosage
  • Benzamides / pharmacology
  • Bridged Bicyclo Compounds / administration & dosage
  • Bridged Bicyclo Compounds / pharmacology
  • Ceruletide / administration & dosage
  • Ethanol / administration & dosage
  • Fatty Acids, Monounsaturated / administration & dosage
  • Injections, Intraperitoneal
  • Lipopolysaccharides / administration & dosage
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Pancreatitis / chemically induced
  • Pancreatitis / drug therapy
  • Pancreatitis / metabolism*
  • Signal Transduction / drug effects
  • alpha7 Nicotinic Acetylcholine Receptor / agonists*
  • alpha7 Nicotinic Acetylcholine Receptor / antagonists & inhibitors
  • alpha7 Nicotinic Acetylcholine Receptor / metabolism*

Substances

  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Benzamides
  • Bridged Bicyclo Compounds
  • Chrna7 protein, mouse
  • Fatty Acids, Monounsaturated
  • Lipopolysaccharides
  • PNU-282987
  • Tcfeb protein, mouse
  • alpha7 Nicotinic Acetylcholine Receptor
  • palmitoleic acid
  • methyllycaconitine
  • Ethanol
  • Ceruletide
  • Aconitine